ETHICS STATEMENT
This project was reviewed and approved by Ethics Committee of the Dr Nélio Mendonça Hospital.
References
1. Huang, C.; Wang, Y.; Li, X.; Ren, L.; Zhao, J.; Hu, Y.; Zhang, L.; Fan, G.; Xu, J.; Gu, X., et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet2020 , 395 , 497-506, doi:10.1016/s0140-6736(20)30183-5.
2. Vasbinder, A.; Padalia, K.; Pizzo, I.; Machado, K.; Catalan, T.; Presswalla, F.; Anderson, E.; Ismail, A.; Hutten, C.; Huang, Y., et al. SuPAR, biomarkers of inflammation, and severe outcomes in patients hospitalized for COVID-19: The International Study of Inflammation in COVID-19. J. Med. Virol. 2024 , 96 , e29389, doi:10.1002/jmv.29389.
3. Kabir, M.A.; Ahmed, R.; Chowdhury, R.; Iqbal, S.M.A.; Paulmurugan, R.; Demirci, U.; Asghar, W. Management of COVID-19: current status and future prospects. Microbes Infect. 2021 , 23 , 104832, doi:10.1016/j.micinf.2021.104832.
4. Talic, S.; Shah, S.; Wild, H.; Gasevic, D.; Maharaj, A.; Ademi, Z.; Li, X.; Xu, W.; Mesa-Eguiagaray, I.; Rostron, J., et al. Effectiveness of public health measures in reducing the incidence of covid-19, SARS-CoV-2 transmission, and covid-19 mortality: systematic review and meta-analysis. BMJ 2021 , 375 , e068302, doi:10.1136/bmj-2021-068302.
5. Li, Y.; Undurraga, E.A.; Zubizarreta, J.R. Effectiveness of Localized Lockdowns in the COVID-19 Pandemic. Am. J. Epidemiol.2022 , 191 , 812-824, doi:10.1093/aje/kwac008.
6. World Health Organization. WHO Coronavirus (COVID-19) Dashboard. Availabe online: (accessed on 21 June 2023).
7. Jones, E.A.K.; Mitra, A.K.; Bhuiyan, A.R. Impact of COVID-19 on Mental Health in Adolescents: A Systematic Review. Int. J. Environ. Res. Public. Health 2021 , 18 , doi:10.3390/ijerph18052470.
8. Ventriglio, A.; Castaldelli-Maia, J.M.; Torales, J.; Chumakov, E.M.; Bhugra, D. Personal and social changes in the time of COVID-19. Ir J Psychol Med 2021 , 38 , 315-317, doi:10.1017/ipm.2021.23.
9. May, T.; Aughterson, H.; Fancourt, D.; Burton, A. ’Stressed, uncomfortable, vulnerable, neglected’: a qualitative study of the psychological and social impact of the COVID-19 pandemic on UK frontline keyworkers. BMJ Open 2021 , 11 , e050945, doi:10.1136/bmjopen-2021-050945.
10. Miyah, Y.; Benjelloun, M.; Lairini, S.; Lahrichi, A. COVID-19 Impact on Public Health, Environment, Human Psychology, Global Socioeconomy, and Education. Scientific World Journal2022 , 2022 , 5578284, doi:10.1155/2022/5578284.
11. Zhang, Y.; Clarke, S.P.; Wu, H.; Li, W.; Zhou, C.; Lin, K.; Wang, J.; Wang, J.; Liang, Y.; Wang, X., et al. A comprehensive overview on the transmission, pathogenesis, diagnosis, treatment, and prevention of SARS-CoV-2. J. Med. Virol. 2023 , 95 , e28776, doi:10.1002/jmv.28776.
12. Abusrewil, Z.; Alhudiri, I.M.; Kaal, H.H.; El Meshri, S.E.; Ebrahim, F.O.; Dalyoum, T.; Efrefer, A.A.; Ibrahim, K.; Elfghi, M.B.; Abusrewil, S., et al. Time scale performance of rapid antigen testing for SARS-CoV-2: Evaluation of 10 rapid antigen assays. J. Med. Virol.2021 , 93 , 6512-6518, doi:10.1002/jmv.27186.
13. Pasomsub, E.; Watcharananan, S.P.; Boonyawat, K.; Janchompoo, P.; Wongtabtim, G.; Suksuwan, W.; Sungkanuparph, S.; Phuphuakrat, A. Saliva sample as a non-invasive specimen for the diagnosis of coronavirus disease 2019: a cross-sectional study. Clin. Microbiol. Infect.2021 , 27 , 285 e281-285 e284, doi:10.1016/j.cmi.2020.05.001.
14. Teymouri, M.; Mollazadeh, S.; Mortazavi, H.; Naderi Ghale-Noie, Z.; Keyvani, V.; Aghababaei, F.; Hamblin, M.R.; Abbaszadeh-Goudarzi, G.; Pourghadamyari, H.; Hashemian, S.M.R., et al. Recent advances and challenges of RT-PCR tests for the diagnosis of COVID-19. Pathol. Res. Pract. 2021 , 221 , 153443, doi:10.1016/j.prp.2021.153443.
15. Merino, P.; Guinea, J.; Munoz-Gallego, I.; Gonzalez-Donapetry, P.; Galan, J.C.; Antona, N.; Cilla, G.; Hernaez-Crespo, S.; Diaz-de Tuesta, J.L.; Gual-de Torrella, A., et al. Multicenter evaluation of the Panbio COVID-19 rapid antigen-detection test for the diagnosis of SARS-CoV-2 infection. Clin. Microbiol. Infect. 2021 , 27 , 758-761, doi:10.1016/j.cmi.2021.02.001.
16. Berenguer, C.V.; Pereira, F.; Pereira, J.A.M.; Camara, J.S. Volatilomics: An Emerging and Promising Avenue for the Detection of Potential Prostate Cancer Biomarkers. Cancers (Basel)2022 , 14 , doi:10.3390/cancers14163982.
17. Silva, C.; Perestrelo, R.; Silva, P.; Tomas, H.; Camara, J.S. Breast Cancer Metabolomics: From Analytical Platforms to Multivariate Data Analysis. A Review. Metabolites 2019 , 9 , 102, doi:10.3390/metabo9050102.
18. Bond, A.; Greenwood, R.; Lewis, S.; Corfe, B.; Sarkar, S.; O’Toole, P.; Rooney, P.; Burkitt, M.; Hold, G.; Probert, C. Volatile organic compounds emitted from faeces as a biomarker for colorectal cancer.Alimentary Pharmacology & Therapeutics 2019 , 49 , 1005-1012, doi:10.1111/apt.15140.
19. Markar, S.R.; Brodie, B.; Chin, S.-T.; Romano, A.; Spalding, D.; Hanna, G.B. Profile of exhaled-breath volatile organic compounds to diagnose pancreatic cancer. BJS (British Journal of Surgery)2018 , 105 , 1493-1500, doi:10.1002/bjs.10909.
20. Taunk, K.; Porto-Figueira, P.; Pereira, J.A.M.; Taware, R.; da Costa, N.L.; Barbosa, R.; Rapole, S.; Câmara, J.S. Urinary Volatomic Expression Pattern: Paving the Way for Identification of Potential Candidate Biosignatures for Lung Cancer. Metabolites2022 , 12 , doi:10.3390/metabo12010036.
21. Opitz, P.; Herbarth, O. The volatilome - investigation of volatile organic metabolites (VOM) as potential tumor markers in patients with head and neck squamous cell carcinoma (HNSCC). J Otolaryngol Head Neck Surg 2018 , 47 , 42, doi:10.1186/s40463-018-0288-5.
22. Sethi, S.; Nanda, R.; Chakraborty, T. Clinical application of volatile organic compound analysis for detecting infectious diseases.Clin. Microbiol. Rev. 2013 , 26 , 462-475, doi:10.1128/CMR.00020-13.
23. Gallagher, M.; Wysocki, C.J.; Leyden, J.J.; Spielman, A.I.; Sun, X.; Preti, G. Analyses of volatile organic compounds from human skin.Br. J. Dermatol. 2008 , 159 , 780-791, doi:10.1111/j.1365-2133.2008.08748.x.
24. Neerincx, A.H.; Vijverberg, S.J.H.; Bos, L.D.J.; Brinkman, P.; van der Schee, M.P.; de Vries, R.; Sterk, P.J.; Maitland-van der Zee, A.-H. Breathomics from exhaled volatile organic compounds in pediatric asthma.Pediatr. Pulmonol. 2017 , 52 , 1616-1627, doi:10.1002/ppul.23785.
25. Kusano, M.; Mendez, E.; Furton, K.G. Comparison of the Volatile Organic Compounds from Different Biological Specimens for Profiling Potential*. J. Forensic Sci. 2013 , 58 , 29-39, doi:10.1111/j.1556-4029.2012.02215.x.
26. Sola-Martínez, R.A.; Sanchez-Solis, M.; Lozano-Terol, G.; Gallego-Jara, J.; García-Marcos, L.; Cánovas Díaz, M.; de Diego Puente, T.; Group, T.N.S. Relationship between lung function and exhaled volatile organic compounds in healthy infants. Pediatr. Pulmonol.2022 , 57 , 1282-1292, doi:10.1002/ppul.25849.
27. Riccio, G.; Berenguer, C.V.; Perestrelo, R.; Pereira, F.; Berenguer, P.; Ornelas, C.P.; Sousa, A.C.; Vital, J.A.; Pinto, M.d.C.; Pereira, J.A.M., et al. Differences in the Volatilomic Urinary Biosignature of Prostate Cancer Patients as a Feasibility Study for the Detection of Potential Biomarkers. Cur. Oncol. 2023 , 30 , 4904-4921.
28. Silva, C.L.; Passos, M.; Camara, J.S. Solid phase microextraction, mass spectrometry and metabolomic approaches for detection of potential urinary cancer biomarkers–a powerful strategy for breast cancer diagnosis. Talanta 2012 , 89 , 360-368, doi:10.1016/j.talanta.2011.12.041.
29. Arthur, C.L.; Pawliszyn, J. Solid-Phase Microextraction with Thermal-Desorption Using Fused-Silica Optical Fibers. Anal. Chem.1990 , 62 , 2145-2148, doi:DOI 10.1021/ac00218a019.
30. Camara, J.S.; Perestrelo, R.; Berenguer, C.V.; Andrade, C.F.P.; Gomes, T.M.; Olayanju, B.; Kabir, A.; C, M.R.R.; Teixeira, J.A.; Pereira, J.A.M. Green Extraction Techniques as Advanced Sample Preparation Approaches in Biological, Food, and Environmental Matrices: A Review. Molecules 2022 , 27 , doi:10.3390/molecules27092953.
31. Pang, Z.; Chong, J.; Zhou, G.; de Lima Morais, D.A.; Chang, L.; Barrette, M.; Gauthier, C.; Jacques, P.E.; Li, S.; Xia, J. MetaboAnalyst 5.0: narrowing the gap between raw spectra and functional insights.Nucleic Acids Res. 2021 , 49 , W388-W396, doi:10.1093/nar/gkab382.
32. Câmara, J.S.; Perestrelo, R.; Berenguer, C.V.; Andrade, C.F.P.; Gomes, T.M.; Olayanju, B.; Kabir, A.; M. R. Rocha, C.; Teixeira, J.A.; Pereira, J.A.M. Green Extraction Techniques as Advanced Sample Preparation Approaches in Biological, Food, and Environmental Matrices: A Review. Molecules 2022 , 27 , doi:10.3390/molecules27092953.
33. de Lacy Costello, B.; Amann, A.; Al-Kateb, H.; Flynn, C.; Filipiak, W.; Khalid, T.; Osborne, D.; Ratcliffe, N.M. A review of the volatiles from the healthy human body. J. Breath Res. 2014 ,8 , 014001, doi:10.1088/1752-7155/8/1/014001.
34. Pang, Z.; Chong, J.; Zhou, G.; de Lima Morais, D.A.; Chang, L.; Barrette, M.; Gauthier, C.; Jacques, P.; Li, S.; Xia, J. MetaboAnalyst 5.0: narrowing the gap between raw spectra and functional insights.Nucleic Acids Res. 2021 , 49 , W388-W396, doi:10.1093/nar/gkab382.
35. Wishart, D.S.; Guo, A.; Oler, E.; Wang, F.; Anjum, A.; Peters, H.; Dizon, R.; Sayeeda, Z.; Tian, S.; Lee, B.L., et al. HMDB 5.0: the Human Metabolome Database for 2022. Nucleic Acids Res. 2022 ,50 , D622-D631, doi:10.1093/nar/gkab1062.
36. Riccio, G.; Berenguer, C.; Perestrelo, R.; Pereira, F.; Berenguer, P.; Ornelas, C.; Sousa, A.; Vital, J.; Pinto, M.; Pereira, J., et al. Differences in the Volatilomic Urinary Biosignature of Prostate Cancer Patients as a Feasibility Study for the Detection of Potential Biomarkers. Cur. Oncol. 2023 , in press .
37. Jala, A.; Dutta, R.; Josyula, J.V.N.; Mutheneni, S.R.; Borkar, R.M. Environmental phenol exposure associates with urine metabolome alteration in young Northeast Indian females. Chemosphere2023 , 317 , 137830, doi:10.1016/j.chemosphere.2023.137830.
38. Buszewski, B.; Ulanowska, A.; Ligor, T.; Jackowski, M.; Klodzinska, E.; Szeliga, J. Identification of volatile organic compounds secreted from cancer tissues and bacterial cultures. J. Chromatogr. B Analyt. Technol. Biomed. Life. Sci. 2008 , 868 , 88-94, doi:10.1016/j.jchromb.2008.04.038.
39. Mills, G.A.; Walker, V. Headspace solid-phase microextraction profiling of volatile compounds in urine: application to metabolic investigations. J. Chromatogr. B Biomed. Sci. Appl.2001 , 753 , 259-268, doi:10.1016/s0378-4347(00)00554-5.
40. Zhang, J.J.; Dong, X.; Liu, G.H.; Gao, Y.D. Risk and Protective Factors for COVID-19 Morbidity, Severity, and Mortality. Clin. Rev. Allergy Immunol. 2023 , 64 , 90-107, doi:10.1007/s12016-022-08921-5.